Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| plasmacytoid dendritic cell | 16 studies | 39% ± 13% | |
| conventional dendritic cell | 15 studies | 27% ± 8% | |
| classical monocyte | 14 studies | 22% ± 8% | |
| macrophage | 14 studies | 24% ± 7% | |
| dendritic cell | 8 studies | 36% ± 17% | |
| monocyte | 8 studies | 21% ± 7% | |
| hematopoietic precursor cell | 6 studies | 40% ± 20% | |
| hematopoietic stem cell | 6 studies | 39% ± 13% | |
| non-classical monocyte | 5 studies | 25% ± 8% | |
| myeloid cell | 5 studies | 24% ± 7% | |
| mast cell | 4 studies | 31% ± 15% | |
| squamous epithelial cell | 4 studies | 42% ± 19% | |
| epithelial cell | 4 studies | 28% ± 8% | |
| megakaryocyte-erythroid progenitor cell | 4 studies | 33% ± 14% | |
| granulocyte monocyte progenitor cell | 3 studies | 36% ± 4% | |
| leukocyte | 3 studies | 22% ± 3% | |
| basal cell | 3 studies | 28% ± 3% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| peripheral blood | 3 studies | 23% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| lung | 98% | 1275.74 | 568 / 578 | 90% | 41.29 | 1042 / 1155 |
| prostate | 91% | 1120.75 | 222 / 245 | 82% | 19.38 | 413 / 502 |
| bladder | 62% | 674.57 | 13 / 21 | 90% | 61.85 | 453 / 504 |
| breast | 63% | 390.88 | 291 / 459 | 74% | 13.27 | 824 / 1118 |
| esophagus | 49% | 3237.81 | 703 / 1445 | 84% | 52.90 | 153 / 183 |
| skin | 72% | 2899.96 | 1301 / 1809 | 44% | 7.94 | 207 / 472 |
| peripheral blood | 99% | 2751.66 | 916 / 929 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 98% | 110.60 | 44 / 45 |
| spleen | 94% | 813.76 | 226 / 241 | 0% | 0 | 0 / 0 |
| pancreas | 1% | 7.91 | 4 / 328 | 90% | 35.08 | 161 / 178 |
| uterus | 5% | 60.08 | 9 / 170 | 86% | 82.43 | 393 / 459 |
| intestine | 19% | 94.62 | 187 / 966 | 71% | 13.93 | 376 / 527 |
| lymph node | 0% | 0 | 0 / 0 | 86% | 23.31 | 25 / 29 |
| stomach | 16% | 88.02 | 59 / 359 | 61% | 9.11 | 174 / 286 |
| adipose | 67% | 478.22 | 804 / 1204 | 0% | 0 | 0 / 0 |
| brain | 21% | 104.00 | 554 / 2642 | 45% | 6.20 | 314 / 705 |
| kidney | 11% | 77.13 | 10 / 89 | 38% | 4.62 | 344 / 901 |
| thymus | 5% | 20.69 | 31 / 653 | 37% | 18.07 | 222 / 605 |
| adrenal gland | 34% | 162.44 | 88 / 258 | 6% | 1.30 | 14 / 230 |
| ovary | 2% | 6.62 | 3 / 180 | 34% | 4.03 | 147 / 430 |
| blood vessel | 31% | 188.83 | 408 / 1335 | 0% | 0 | 0 / 0 |
| liver | 4% | 20.01 | 8 / 226 | 6% | 1.04 | 26 / 406 |
| heart | 6% | 27.64 | 48 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 1% | 0.10 | 1 / 80 |
| muscle | 0% | 1.47 | 2 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007188 | Biological process | adenylate cyclase-modulating G protein-coupled receptor signaling pathway |
| GO_0001508 | Biological process | action potential |
| GO_0060158 | Biological process | phospholipase C-activating dopamine receptor signaling pathway |
| GO_0019722 | Biological process | calcium-mediated signaling |
| GO_0007207 | Biological process | phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway |
| GO_0005834 | Cellular component | heterotrimeric G-protein complex |
| GO_0045202 | Cellular component | synapse |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0031683 | Molecular function | G-protein beta/gamma-subunit complex binding |
| GO_0005525 | Molecular function | GTP binding |
| GO_0003924 | Molecular function | GTPase activity |
| GO_0046872 | Molecular function | metal ion binding |
| GO_0001664 | Molecular function | G protein-coupled receptor binding |
| Gene name | GNA15 |
| Protein name | G protein subunit alpha 15 Guanine nucleotide-binding protein subunit alpha-15 (G alpha-15) (G-protein subunit alpha-15) (Epididymis tissue protein Li 17E) (Guanine nucleotide-binding protein subunit alpha-16) (G alpha-16) (G-protein subunit alpha-16) |
| Synonyms | GNA16 |
| Description | FUNCTION: Guanine nucleotide-binding proteins (G proteins) are involved as modulators or transducers in various transmembrane signaling systems. |
| Accessions | P30679 ENST00000592455.1 K7EP74 ENST00000262958.4 |